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PD-1 EXPRESSION IS LINKED TO CMV DISEASE AND PROLONGED CMV
INFECTION AFTER HCT
Gallez-Hawkins, G.M.1, Thao, L.1, Palmer, J.2, Li, X.1, Franck, A.E.1,
Lacey, S.F.3, Diamond, D.J.3, Forman, S.J.4, Zaia, J.A.1. 1Beckman Re-
search Institute of City of Hope, Duarte, CA; 2City of Hope, Duarte, CA;
3Beckman Research Institute of City of Hope, Duarte, CA; 4City of Hope,
Duarte, CA.
PD-1 expression has been linked to chronic viral infection in both
mice (Barber DL et al, Nature 2006, 7077: 682–7) and man (Traut-
mann L et al Nat Med.2006; 10:1198–202). Although PD-1 expres-
sion has not been shown to be up-regulated in CMV-specific CD81
T cells of HIV-infected subjects, recently the up-regulation of PD-
1 has been associated with CMV disease after liver transplantation
(LaRosa et al. J. Infect Dis in press 2007). The question of whether
PD-1 expression influences the course of CMV infection after HCT
is unknown. We hypothesized that if PD-1 expression is associated
with risk for prolonged infection or disease, then it would be up-
regulated on CD41 and CD81T cells of HCT recipients with
CMV infection and disease.
Method: Subjects were followed prospectively for CMV-specific
immune reconstitution after HCT. Subsets of these subjects were
selected based on demonstration of prolonged CMV infection,
defined as .10 positive CMV qPCR assays in the first 100 days
post-HCT (n 5 14), development of CMV disease (n 5 14), or
a non-CMV viremic group (n 5 25). These were tested for
CD41 and CD81/PD11 expression by FACS analysis. The MFI
(mean fluorescence intensity) of PD-1 expression was reported for
unstimulated, pp65-peptide mixture and HIV-peptide mixture
[Pepmix] (negative control) stimulated cells, at days 90, 120, 180,
and 360 post transplant, and analyzed statistically using the non-
parametric Mann-Whitney test (www.graphpad.com). Results:
The PD-1 expression (MFI) was significantly higher in CD41
(p\ 0.004) and CD81 (p\ .009) lymphocytes at days 90, 120,
and 180 post-HCT in the CMV disease group than the non-viremic
group. For the group with prolonged viremia, the PD-1 expression
was significantly higher only for the CD81 cells (p\0.05) at these
same times. However, the total number of PD-1 positive cells was
not different between these groups. At day 360 post-transplant,
the PD1 MFI values did not differ between groups. When CD4
or CD8 cells were stimulated in vitro at these observation points, us-
ing either pp65 Pepmix or control HIV Pepmix, a similar significant
difference between CMV disease group and non-viremic group was
observed (p\0.007 for both CD41 and CD81 cells).Conclusion:
CMV disease and prolonged viremia in HCT subjects is associated
with higher expression of PD-1 and could manifest T cell exhaus-
tion, detectible by day 90 post-HCT. This could be an important
risk factor in development of subsequent CMV disease in HCT
recipients.403
DAY 15 DENDRITIC CELL RECOVERY PREDICTS OVERALL SURVIVAL AF-
TER AUTOLOGOUS STEM CELL TRANSPLANTATION IN NON-HODGKIN’S
LYMPHOMA
Siddiqui, M.A., Markovic, S.N., Nevala, W.K., Morice, W.,
Inwards, D.J., Ansell, S.M., Micallef, I.N., Johnston, P.B., Porrata, L.
Mayo Clinic, Rochester, MN.
The peripheral blood absolute lymphocyte count (ALC) on day
15 after autologous stem cell transplantation (ASCT) has been
shown to be an independent predictor for overall survival (OS) for
many malignancies including acute myelogenous leukemia
(AML), breast cancer, multiple myeloma (MM), primary systemic
amyloidosis, and Hodgkin’s and non-Hodgkin’s lymphoma
(NHL). A recent report (Dean et al. BMT 2005; 36, 1049–1052)
suggested that infused autograft dendritic cells (DC) affect survival
post-ASCT in NHL. Thus, DC recovery at day 15 post-ASCT was
assessed and correlated with OS. Preliminary data from an ongoing
prospective study of 28 NHL patients post-ASCT are reported. Ab-
solute DC at day 15 was analyzed by four color flow cytometry using
antibodies to CD3, CD14, CD16, and CD19. In this approach lym-phocytes and DCs were initially gated by their similar forward and
side light scatter characteristics; DCs were then identified as cells in
this gate that lacked staining for the lymphocyte antigens CD3,
CD16, and CD19 and the monocyte antigen CD14. The percent-
age of antigen negative cells cells in the lymphocyte gate was then
multiplied by the coincident peripheral blood absolute lymphocyte
to determine the absolute DC count. Survival was then analyzed us-
ing the Kaplan-Meier method. With a median follow-up of 18
months, patients recovering a DC of 10 cells/ml or above experi-
enced superior median OS versus those who did not (not reached
vs 21 months, p\0.02). This study shows that an immunocompe-
tent immune system at day 15 (not only ALC recovery, but also DC
recovery) correlates with survival in NHL patients undergoing
ASCT. This study was supported in part by the Grant CA90628–
04A from the National Institute of Health, and the University of
Iowa/Mayo Clinic Lymphoma Spore CA97274.404
RECONSTITUTION OF TCR REPERTOIRE DIVERSITY VIA HOMEOSTATIC
PROLIFERATION AFTER BONE MARROW TRANSPLANTATION
Zilberberg, J., Friedman, T.M., Korngold, R. Hackensack University
Medical Center, Hackensack, NJ.
The ability to mount protective immune responses depends upon
the existence of a diverse T cell repertoire. After age-related thymic
involution, the pool of naive and memory T cells is maintained con-
stant by a variety of thymus-independent homeostatic and cytokine-
driven proliferation mechanisms. Patients undergoing autologous
or allogeneic blood and marrow transplantation (BMT) often expe-
rience difficulties regaining a diverse TCR repertoire. Under these
lymphopenic conditions, homeostatic proliferation of mature do-
nor T cells from the stem cell innoculum greatly contributes to T
cell repertoire reconstitution. In examining reconstitution of the
CD8 and CD4 subsets following BMT, it is well known that the
numbers of CD41 T cells lag far behind the numbers of CD81,
and while many studies have focused on the factors contributing
to proliferation of donor T cells after BMT, the relationship be-
tween transplanted T cell numbers and reconstitution of a diverse
TCR repertoire has yet to be determined. To examine this relation-
ship we utilized a syngeneic transplant model, in which lethally ir-
radiated C57BL/6 (B6) mice received limited numbers (1  105
and 5  105) of B6eGFP1 T cells along with B6 T cell-depleted
bone marrow cells for hematopoietic reconstitution. At 15 and 60
days post-BMT, homeostatically proliferating eGFP1 T cells, har-
vested from the spleen and lymph nodes of recipient mice, were se-
lected by fluorescence activated cell sorting, and TCR Vb CDR3-
size spectratype analysis was used to examine repertoire complexity
of the CD41 and CD81 T cell populations. This analysis revealed
that as early as 15 days post-BMT, the CD81 subset exhibited 85%
overall complexity, whereas only 55% of the CD41 subset was com-
plex at day 60. This study will provide a better understanding of the
minimal cellular requirements for obtaining a complex repertoire,
which is especially critical for improving the clinical outcome of
transplanted individuals with diminished thymic activity.405
FATE OF THE CD41FOXP31 SUBSET WITHIN THE TOTAL CD41 T CELL
POPULATION FOLLOWING BMT
Zilberberg, J., Friedman, T.M., Korngold, R. Hackensack University
Medical Center, Hackensack, NJ.
Using murine bone marrow transplant model systems, it has been
demonstrated that the administration of exogenous regulatory T
cells (Treg), either at the time of transplant or several days later
as a delayed lymphocyte infusion, can effectively ameliorate the del-
eterious effects of graft-versus-host disease (GVHD) while preserv-
ing graft-versus-leukemia effects. Similarly, the question arises as to
whether homeostatic proliferation of donor-derived Treg could
Poster Session II 147potentially prevent the occurrence of GVHD if it were determined
that these cells underwent sufficient homeostatic proliferation to
generate the Treg:effector T cell ratios required to accomplish
this effect. While several studies have focused on the proliferation
of transferred CD41CD251 T cells, it is well known that CD25
is also present on activated T cells, and hence is not a definitive
marker for identifying Treg. In contrast, the transcription factor,
FoxP3, has been determined to be a more definitive marker. With
this in mind, we injected unseparated CD41 T cells from C57BL/
6 (B6) GFP1FoxP3 knock-in mice into lethally irradiated B6 recip-
ients to study the proliferation and homing potential of Treg in the
context of other T cells. On days 2 and 7 post-transplant, GFP1
cells were found in the spleen of recipient mice at double the num-
ber of those found in the mesenteric lymph nodes. Furthermore, in
contrast to previously published results in which only CD41CD251
T cells were injected and proliferation was reported, our experimen-
tal design should help to elucidate the fate of FoxP31 Treg under
conditions that more closely represent BMT; where Treg constitute
part of the transferred T cell population.406
EFFECT OF IL-7 ON HUMAN NK CELLS
Michaud, A., Dardari, R., Charrier, E., Cordero, P., Duval, M. Hoˆpital
Ste-Justine, Montreal, QC, Canada.
Background: NK cells are first immune cells to reappear after
HSCT and their activation may play a role in transplantation out-
come. IL-7 is currently under clinical investigation as a therapeutic
agent after HSCT. We demonstrated that human NK cells express
IL-7 receptor, with a higher expression by CD56bright NK cells. We
thus investigated the effect of IL-7 on NK cells. Methods: Activa-
tion markers were studied by flow cytometry, as well as inhibitory
receptors expression. Proliferation assays were performed by
CFSE staining. Cytotoxicity was studied by 51Cr release assay.
Results: IL-7 induced the expression of CD25 and CD69 and en-
hanced NKG2D expression. The expression pattern of inhibitory
receptors was altered by IL-7: fewer cells expressed KIR, whereas
more cells expressed NKG2A. IL-7 induced the proliferation of
CD56bright NK cells, but not the proliferation of CD56dim NK cells.
Cytotoxicity was increased in 4 out of 7 donors. Conclusion: The
effect of IL-7 on NK cells differs from one donor to another and
from a NK cells subset to another. This must be taken into account
in the interpretation of the results of clinical trials of IL-7 after
HSCT.407
PLASMATIC TNF-a, IL-2, IFN-g AND IL-10 ARE IMPORTANT CYTOKINES
TO CONTROL CML AFTER ALLOGENEIC STEM CELL TRANSPLANT
Anjos, A.R.1, Silva, L.1, Kaneno, R.2, Calvi, S.2, Oliveira, J.S.R.1. 1Uni-
versity Federal of Sao Paulo, Sao Paulo, Brazil; 2University State of Sao
Paulo, Botucatu, Sao Paulo, Brazil.
We correlated mRNA and plasmatic TNF-a, IL-2, IFN-g and
IL-10 levels with engraftment, VOD, acute and chronic GvHD in
CML patients underwent to allogeneic BMT. There was no corre-
lation between plasmatic and mRNA cytokines during one year fol-
low-up. Plasmatic TNF-a and IL-10 were not related to acute and
chronic GvHD. In d1 30, patients suffered from acute-GvHD had
lower mRNA IL-2 and IFN-g than those without this involvement
and both were lower than controls. At d 1 360, IFN-g mRNA was
similar, IL-2 mRNA lower and plasmatic IFN-g higher than con-
trols. We showed that IL-2 mRNA is applicable to diagnosis of
chronic GvHD at d 1 180. Lately in the follow-up, we noted as
much as plasmatic TNF-a was decreased, either was IL-10; how-
ever IFN-g and IL-2 were increased. These data ruled out plasmatic
IFN- g and IL-2 as control disease cytokines that prevailed in the
chronic GvHD stable phase after allogeneic BMT.TRANSPLANT NURSING
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PERCEPTION OF KNOWLEDGE OF THE STEM CELL TRANSPLANT (SCT)
PROCESS AND EVALUATION OF SCT TEAM MEMBER FUNCTIONS BY
CAREGIVER(S): A COMPARISON BETWEEN CHILDHOOD MALIGNANT
AND NON-MALIGNANT DISORDER TRANSPLANT FAMILIES
Chadakhtzian, A.L.1, Heidotten, A.1, Yocco, M.1, Barnes, Y.J.1,
Shenoy, S.2. 1St. Louis Children’s Hospital, St. Louis, MO; 2Washington
University School of Medicine, St. Louis, MO.
Background: Allogeneic SCT recipients/families undergo edu-
cational and supportive meetings with a multi-disciplinary team
consisting of nurse coordinator, social worker, child life specialist,
financial specialist, school liaison and child psychologist. Meetings
provide education for SCT procedure. The goal is to promote un-
derstanding of benefits/risks of SCT focusing on helping families
prepare, provide medical, financial, social help and support. Aim:
Quality assessment questionnaire was developed to (1) evaluate
caregiver knowledge of process of SCT (pre-transplant testing, tox-
icities/complications of SCT, post transplant care) for the recipient
diagnosed with malignant/non-malignant disorder and (2) evaluate
perceptions of the role of multidisciplinary team. Methods: Eleven
questionnaires handed to caregivers at discharge from SCT unit to
complete and return anonymously. Questionnaires consisted of 10
questions. Each question was ranked from 1–5 with 5 being the
best. Responses scored 5 were interpreted as excellent, 3–4 consid-
ered good, 1–2 poor level of understanding requiring attention.Re-
sults: 11/11 questionnaires returned/analyzed during 2006–2007
(compliance 100%). Five returned by caregivers of SCT recipients
with malignant disorders and 6 non-malignant disorders. Care-
givers scored understanding of pre-transplant testing, toxicities,
and post transplant care between 3–5. Nurse coordinator, social
worker and child life specialist perceived most important compo-
nents of team. Nurse coordinator and child life specialist received
scores 4–5 from both groups; social worker received scores 4–5
from non-malignant group and 2–5 from malignant group. Finan-
cial specialist, school liaison, and child psychologist received scores
1–5 from both groups. Conclusions: Study suggests no difference
in perceptions of SCT process and education between families of
malignant/non-malignant disorders, and needs to be validated
with larger numbers. Results indicate families are comfortable
with medical information provided regarding SCT and social inter-
actions. The lower scoring of ancillary services suggest an incom-
plete understanding of their role perhaps due to absence of
tangible outcome measures and needs to be emphasized during
pre-transplant education.409
MAD ABOUT STEROIDS: NURSING MANAGEMENT OF THE SCT PATIENT
WITH STEROID-INDUCED PSYCHOSIS
Switzer, M.A. The University of Texas MD Anderson Cancer Center,
Houston, TX.
Prolonged courses of high dose steroids are frequently used to
manage graft vs. host disease (GVHD) following allogeneic stem
cell transplant (SCT). Among the known complications of pro-
longed steroid treatment are mental status changes, effecting up
to 40% of all transplant recipients. Five percent of these alterations
are considered ‘‘severe’’. Symptoms generally present within two
weeks of initiating high-dose therapy. Often manifesting as a persis-
tent, hallucinatory state, these episodes of ‘‘steroid psychosis’’ pres-
ent significant nursing challenges. Patients can be combative,
agitated and are usually noncompliant with treatment regimes. In-
patient SCT nurses often find themselves unprepared to manage
the complex medical and psychosocial needs of patients with acute
psychosis.
Existing literature offers no standard protocols and little guid-
ance to support an evidence-based approach to the nursing manage-
ment of SCT patients with steroid induced psychosis requiring
long-term hospitalization. A clear need exists to educate nurses co-
ordinating care for this rare but serious side effect of transplant ther-
apy. This poster will bridge the gap and provide nurses insight into
